Johnson Johnson Just Paid a $1B Bet on Undruggable Target
When a global pharma giant drops $1 billion on a single tech, investors sit up. This move by Johnson Johnson Just Pai...
Planning for retirement at 50? Focus on crucial considerations to secure your financial future and enjoy your golden years.
21,341 articlesWhen a global pharma giant drops $1 billion on a single tech, investors sit up. This move by Johnson Johnson Just Pai...
As AI evolves, investors face a choice: a defense-first, multi-year government play or a fast-growing consumer voice ...
A major fund recently disclosed a sizable bet on The Andersons, flashing confidence in the agribusiness sector. This ...
Clark Howard weighs in on helping a family member build credit without jeopardizing your own score, after a May 11, 2...
Navitas Semiconductor carved out a standout session as investors reassessed growth catalysts in power semiconductors....
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
A notable stake by 140 Summer Partners LP in Acuity Brands is turning heads in the investing world. This article brea...
Teva is shifting from a debt-laden generic player to a branded-focused pharma with a stronger balance sheet. This piv...
SpaceX's record IPO ignited a heated spacex wall street debating about AI spending and market risk. This piece breaks...
Investors weighing Dow and LYB face a crossroads in 2026. This guide breaks down business models, catalysts, risks, a...
A notable hedge fund takes a sizable new position in SentinelOne, signaling growing confidence in AI-driven cybersecu...
A single data point is grabbing attention: XRP-led real-world asset tokenization is surpassing ETH and SOL inflows. W...